Ornopia, Roy L.

HRN: 11-59-83  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2023
CEFTRIAXONE 1G (VIAL)
08/02/2023
08/09/2023
IVT
2gms
Od
Pneumohydrothorax Prob Sec To Ruptured Bleb Sec To Ptb Cannot Totally Rule Out Parapneumonic Process
Waiting Final Action 
08/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2023
08/16/2023
IV
1.5g
Q6 H
Pneumohydrothorax Sec To PTB
Waiting Final Action 
08/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/14/2023
08/20/2023
IV
4.5
Q8
Sepsis/pneumonia
Waiting Final Action 
08/23/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/23/2023
09/06/2023
TOPICAL
Thinly Apply
OD
Skin Infection
Waiting Final Action 
09/06/2023
CEFTAZIDIME 1GM (VIAL)
09/06/2023
09/12/2023
IV
2gm
Q8
Cap Mr
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: